| Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products L Yin, X Chen, P Vicini, B Rup, TP Hickling Cellular Immunology 295 (2), 118-126, 2015 | 85 | 2015 |
| Human CD4+ T Cell Response to Human Herpesvirus 6 MD Nastke, A Becerra, L Yin, O Dominguez-Amorocho, L Gibson, ... Journal of virology 86 (9), 4776-4792, 2012 | 82 | 2012 |
| Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide–MHC complexes LM Hellman, L Yin, Y Wang, SJ Blevins, TP Riley, OS Belden, TT Spear, ... Journal of immunological methods 432, 95-101, 2016 | 76 | 2016 |
| HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM–mediated half-lives L Yin, JM Calvo-Calle, O Dominguez-Amorocho, LJ Stern The Journal of Immunology 189 (8), 3983-3994, 2012 | 59 | 2012 |
| The dendritic cell major histocompatibility complex II (MHC II) peptidome derives from a variety of processing pathways and includes peptides with a broad spectrum of HLA-DM … CC Clement, A Becerra, L Yin, V Zolla, L Huang, S Merlin, A Follenzi, ... Journal of Biological Chemistry 291 (11), 5576-5595, 2016 | 58 | 2016 |
| Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide L Yin, P Trenh, A Guce, M Wieczorek, S Lange, J Sticht, W Jiang, ... Journal of Biological Chemistry 289 (34), 23449-23464, 2014 | 58 | 2014 |
| Measurement of peptide binding to MHC class II molecules by fluorescence polarization L Yin, LJ Stern Current protocols in immunology 106 (1), 5.10. 1-5.10. 12, 2014 | 42 | 2014 |
| A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus JAB Babon, J Cruz, FA Ennis, L Yin, M Terajima Journal of virology 86 (17), 9233-9243, 2012 | 40 | 2012 |
| Evaluating the role of HLA-DM in MHC class II–peptide association reactions L Yin, ZJ Maben, A Becerra, LJ Stern The Journal of Immunology 195 (2), 706-716, 2015 | 28 | 2015 |
| The role of aggregates of therapeutic protein products in immunogenicity: an evaluation by mathematical modeling L Yin, X Chen, A Tiwari, P Vicini, TP Hickling Journal of Immunology Research 2015 (1), 401956, 2015 | 26 | 2015 |
| CD4+ T Cells Provide Intermolecular Help to Generate Robust Antibody Responses in Vaccinia Virus–Vaccinated Humans L Yin, JM Calvo-Calle, J Cruz, FK Newman, SE Frey, FA Ennis, LJ Stern The Journal of Immunology 190 (12), 6023-6033, 2013 | 25 | 2013 |
| HLA-DM focuses on conformational flexibility around P1 pocket to catalyze peptide exchange L Yin, LJ Stern Frontiers in immunology 4, 336, 2013 | 17 | 2013 |
| A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC50 determination L Yin, LJ Stern Journal of immunological methods 406, 21-33, 2014 | 13 | 2014 |
| Simone Merlin 3, Antonia Follenzi, Scott A. Shaffer 4, 5, Lawrence J. Stern 2, 4, Laura CC Clement, A Becerra, L Yin, V Zolla, L Huang | | 2016 |
| Studies of HLA-DM in Antigen Presentation and CD4+ T Cell Epitope Selection: A Dissertation L Yin | | 2014 |
| A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus JAB Babon, J Cruz, FA Ennis, L Yin, M Terajima Journal of Virology 87 (16), 9396-9396, 2013 | | 2013 |
| MHC II-peptide complex conformation constrained by interactions throughout the peptide binding groove determines HLA-DM susceptibility (P5014) L Yin, P Trenh, L Stern The Journal of Immunology 190 (1_Supplement), 41.8-41.8, 2013 | | 2013 |
| Characterization of HLA-DM susceptibility of MHC II-peptide complex in antigen presentation and epitope selection (100.54) L Yin, M Calvo-Calle, L Stern The Journal of Immunology 186 (1_Supplement), 100.54-100.54, 2011 | | 2011 |
